Products for Research Use Only
RegisterLogin

MDL-28170

CAT: 0804-HY-18236-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18236-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MDL-28170 (Calpain Inhibitor III) is a potent, selective and membrane-permeable cysteine protease inhibitor of calpain that rapidly penetrates the blood-brain barrier following systemic administration[1][2]. MDL-28170 also block γ-secretase[4].
CAS Number
88191-84-8
Product Name Alternative
Calpain Inhibitor III
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/MDL-28170.html
Concentration
10mM
Purity
97.0
Solubility
DMSO : 30 mg/mL (ultrasonic; warming)
Smiles
O=C(N[C@@H](C(C)C)C(NC(CC1=CC=CC=C1)C=O)=O)OCC2=CC=CC=C2
Molecular Formula
C22H26N2O4
Molecular Weight
382.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Chen ZF, et al. Neuronal recovery after moderate hypoxia is improved by the calpain inhibitor MDL28170. Brain Res. 1997 Sep 19;769 (1) :188-92.|[2]Li PA, et al. Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neurosci Lett. 1998 May 8;247 (1) :17-20.|[3]Ai J, et al. Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. J Neurotrauma. 2007 Jun;24 (6) :960-78.|[4]De Strooper B, et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999 Apr 8;398 (6727) :518-22.|[5]Kharatmal SB, et al. Calpain inhibitor, MDL 28170 confer electrophysiological, nociceptive and biochemical improvement in diabetic neuropathy. Neuropharmacology. 2015 Oct;97:113-21.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-141426-01MDL-860
HY-112252MDL 73811
HY-105528MDL-25637
HY-105340MDL 27266
HY-119376-01MDL-800
HY-105462MDL 105212A
HY-W975902MDL-27531
HY-16312-01MDL-29951
HY-100621-01MDL 72527
HY-105517MDL 27032

Alternative Products

CatalogName
A4412-5.1MDL 28170
sc-201301CMDL-28170
A15303-100MDL 28170 100mg
A15303-5MDL 28170 5mg

Popular Products